MedPage Today on MSN

Diabetic Donor Corneas Show Success in Transplants for Endothelial Dysfunction

A secondary analysis from an earlier trial found that transplants from donors with diabetes had a higher failure rate and ...
Ophthalmology Times

Aurion Biotech releases positive 12-month results from phase 1/2 CLARA trial

Aurion Biotech has released positive 12-month results from its phase 1/2 CLARA trial evaluating the safety, efficacy, and ...

Aurion Biotech Achieves All Primary, Secondary, and Exploratory Endpoints in AURN001 Phase 1/2 CLARA Trial at 12 Months

Aurion Biotech, a clinical-stage regenerative medicine company with a mission to restore vision to millions of patients, ...
News-Medical.Net on MSN

Fortress, filter, and gatekeeper: New insights into how the blood-brain barrier safeguards the brain

Researchers provide a comprehensive overview of the blood-brain barrier (BBB), detailing its cellular architecture, transport ...